Trial intelligence / Profile preview

Vitamin K for Age-Related Bone Loss and Vascular Calcification

NCT00183001Phase 3Completed

Sponsor
National Institute on Aging
Start
Oct 2001
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in osteoporosis and Vascular calcification comparing Vitamin K with Placebo (2 arms). Primary endpoints: Bone Mineral Density at the Hip at 3 years, Coronary Calcification Score at 3 years and 2 more. Started Oct 2001; status: completed.

02

Drugs

phytomenadione
03

Conditions

osteoporosisVascular calcification

Beyond the preview

Go deeper on NCT00183001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00183001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call